English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The birth of ChatGPT, a cutting-edge language model-based chatbot developedby OpenAI, ushered in a new era in AI. However, due to potential pitfalls, itsrole in rigorous scientific research is not clear yet. This paper vividlyshowcases its innovative application within the field of drug discovery.Focused specifically on developing anti-cocaine addiction drugs, the studyemploys GPT-4 as a virtual guide, offering strategic and methodologicalinsights to researchers working on generative models for drug candidates. Theprimary objective is to generate optimal drug-like molecules with desiredproperties. By leveraging the capabilities of ChatGPT, the study introduces anovel approach to the drug discovery process. This symbiotic partnershipbetween AI and researchers transforms how drug development is approached.Chatbots become facilitators, steering researchers towards innovativemethodologies and productive paths for creating effective drug candidates. Thisresearch sheds light on the collaborative synergy between human expertise andAI assistance, wherein ChatGPT's cognitive abilities enhance the design anddevelopment of potential pharmaceutical solutions. This paper not only exploresthe integration of advanced AI in drug discovery but also reimagines thelandscape by advocating for AI-powered chatbots as trailblazers inrevolutionizing therapeutic innovation.

ChatGPT in Drug Discovery: A Case Study on Anti-Cocaine Addiction Drug Development with Chatbots